Several studies showed that chemotherapy could result in immunological effects by enhancing the cross-presentation of tumor antigens, reducing T-regulatory cell activity, and inducing the expression of PD-L1 on tumor cells, thereby synergistically enhancing the anti-tumor activity of the PD1/PDL1 inhibitor (37–40). The gene discussed is CD274; the disease is neoplasm.